Skip to content
Stop using now Drug recall · FDA · Published December 3, 2014

Hospira Recalls MitoXANTRONE Injection Due to Stability Failures

Hospira recalls specific lots of MitoXANTRONE Injection USP due to failed stability specifications, resulting in subpotency and impurities.

🇺🇸 FDA recall #D-0433-2015DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling MitoXANTRONE Injection, USP (concentrate) 2 mg/mL because the product failed stability specifications. This means the drug may be subpotent and contain out-of-specification known and unknown impurities. The recall affects 13,792 vials distributed in the United States and other countries. Read more at govinfonow.com/recall/45139-hospira-inc-recalls-mitoxantrone-injection-usp-concentrate-2-mg-ml.

Source Summary by GovInfoNow · govinfonow.com/recall/45139-hospira-inc-recalls-mitoxantrone-injection-usp-concentrate-2-mg-ml · Updated October 12, 2026 · FDA enforcement record: FDA #D-0433-2015

Cite this page

“Hospira Recalls MitoXANTRONE Injection Due to Stability Failures.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45139-hospira-inc-recalls-mitoxantrone-injection-usp-concentrate-2-mg-ml. Based on FDA recall #D-0433-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0433-2015%22&limit=1).

The FDA announced on 2014-12-03 that Hospira Inc. voluntarily recalled MitoXANTRONE Injection, USP due to failed stability specifications. The drug is subpotent and contains out-of-specification impurities.

How to tell if you have it

  • Brand: Hospira
  • Product: MitoXANTRONE Injection USP (concentrate) 2 mg/mL
  • NDC: 61703-343-18, Lot Z054636AA (Expiry December 2014)
  • NDC: 61703-343-65, Lot A014645AA (Expiry November 2015)
  • NDC: 61703-343-66, Lot A014643AA (Expiry April 2015)

The hazard

The product failed stability specifications, resulting in subpotency and the presence of out-of-specification known and unknown impurities.

Context

GovInfoNow's records show Hospira Inc. has had 108 other recalls since 2012-04-05. Other recent recalls include a 2017-04-21 recall for hair particulates in syringes and a 2016-11-01 recall for broken ampule tips.

How to tell if you have this one

Check if you have MitoXANTRONE Injection, USP (concentrate) 2 mg/mL manufactured by Hospira Inc. Look for these specific NDC numbers: 61703-343-18, 61703-343-65, or 61703-343-66. Verify the lot numbers and expiry dates against the record: Lot Z054636AA (Exp Dec 2014), Lot A014636AA (Exp Apr 2015), Lot A024636AB (Exp Jul 2015), Lot A014645AA (Exp Nov 2015), or Lot A014643AA (Exp Apr 2015).

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Healthcare Provider

    Inform your doctor or pharmacist immediately if you have received any of the recalled lots to determine next steps for your treatment.

  2. Do Not Use Recalled Vials

    Stop using any vials matching the recalled lot numbers and NDCs until you receive guidance from your healthcare provider or Hospira.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “US: Nationwide including Puerto Rico; Australia, Canada, Cyprus, Egypt, Ireland, Saudi Arabia, Qatar, Oman, Bahrain, and United Kingdom.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 2 years after the firm started it.

1. Firm started the recall: Dec 3, 201412. FDA classified it Class I: Apr 6, 201523. Published in FDA’s Enforcement Report: Apr 15, 201534. FDA terminated the recall: Dec 2, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Where was this product sold?

It was distributed nationwide in the United States (including Puerto Rico) as well as in Australia, Canada, Cyprus, Egypt, Ireland, Saudi Arabia, Qatar, Oman, Bahrain, and the United Kingdom.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0433-2015 (December 3, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0433-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA